Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 5000.00 | 4101.40 | 2972.00 | 5883.75 | 0.5051 | -0.4613 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 5000.00 | 4101.40 | 5837.00 | 5883.75 | 0.9921 | 0.9696 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 2364.00 | 5883.75 | 0.4018 | -0.6530 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5964.00 | 5883.75 | 1.0136 | 1.0527 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5995.00 | 5883.75 | 1.0189 | 1.0733 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5358.00 | 5883.75 | 0.9106 | 0.6709 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5641.00 | 5883.75 | 0.9587 | 0.8445 | |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 5000.00 | 4101.40 | 2938.00 | 5883.75 | 0.4993 | -0.4731 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 5000.00 | 4101.40 | 5694.00 | 5883.75 | 0.9678 | 0.8780 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5723.00 | 5883.75 | 0.9727 | 0.8964 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 5000.00 | 4101.40 | 3067.00 | 5883.75 | 0.5213 | -0.4278 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 6092.00 | 5883.75 | 1.0354 | 1.1382 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 6004.00 | 5883.75 | 1.0204 | 1.0793 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 6091.00 | 5883.75 | 1.0352 | 1.1375 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 6141.00 | 5883.75 | 1.0437 | 1.1713 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 5000.00 | 4101.40 | 5836.00 | 5883.75 | 0.9919 | 0.9689 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5604.00 | 5883.75 | 0.9525 | 0.8214 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5980.00 | 5883.75 | 1.0164 | 1.0633 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5933.00 | 5883.75 | 1.0084 | 1.0323 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 5743.00 | 5883.75 | 0.9761 | 0.9091 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 6057.00 | 5883.75 | 1.0294 | 1.1146 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 5000.00 | 4101.40 | 5912.00 | 5883.75 | 1.0048 | 1.0185 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 5890.00 | 5883.75 | 1.0011 | 1.0041 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 5000.00 | 4101.40 | 6030.00 | 5883.75 | 1.0249 | 1.0966 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5762.00 | 5883.75 | 0.9793 | 0.9213 |